がん診断における人工知能の世界市場レポート 2025年

がん診断における人工知能の市場規模は、今後数年で飛躍的な成長が見込まれます。2029年にはCAGR31.2％で15億5,000万米ドルに成長します。予測期間の成長は、臨床医の不足、人口の高齢化、世界の遠隔医療の導入、aiと電子カルテの統合、がん検診プログラムの増加などに起因しています。予測期間の主な動向には、aiアルゴリズムの急速な進歩、画像技術の進歩、病理学の技術革新、ラジオミクスとラジオゲノミクスの進歩、薬剤開発、ディープラーニング、予測バイオマーカー発見のためのaiなどが含まれます。

がんの有病率の増加は、将来的にがん診断における人工知能市場の成長を促進すると予想されます。がんは、様々な臓器に影響を及ぼす制御不能な細胞増殖を特徴とし、世界中の罹患率と死亡率に大きく寄与しています。人工知能は、医療用画像データの正確かつ効率的な分析を可能にすることで、がん診断において重要な役割を果たしており、がん病変の早期発見と正確な分類に役立っています。例えば、2024年2月、スイスを拠点とする政府間機関である世界保健機関（WHO）は、2022年には約2,000万人のがん患者が新たに発生し、970万人が死亡したと報告しました。がんと診断されてから5年後に生存していた人の数は、推定5,350万人でした。したがって、がん有病率の上昇は、がん診断における人工知能市場の成長を後押しすると予想されます。

ヘルスケア・インフラの継続的な強化が、当面のがん診断における人工知能市場を牽引する見通しです。ヘルスケア・インフラは、ヘルスケア・サービスを支える基本的な枠組み、施設、リソース、プロセスを包含しており、AI技術をシームレスに統合するために極めて重要です。堅牢なヘルスケア・インフラは、臨床ワークフローへのAIの組み込みを可能にし、データのセキュリティとプライバシーを保証し、医療機関間の協力的な取り組みを促進します。注目すべきは、2022年3月、オーストラリアのヘルスケア・高齢者医療省が、2022-23年に1,320億米ドル、2025-26年に1,400億米ドルの大幅な医療インフラへの割り当てを発表したことです。今後4年間で5,370億米ドルというこのコミットメントは、がん診断における人工知能市場を推進する上で、ヘルスケア・インフラの改善が極めて重要な役割を果たすことを強調しています。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場：金利、インフレ、地政学、コロナ禍、回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界のがん診断における人工知能PESTEL分析（政治、社会、技術、環境、法的要因、促進要因、抑制要因）
• 最終用途産業の分析
• 世界のがん診断における人工知能市場：成長率分析
• 世界のがん診断における人工知能市場の実績：規模と成長, 2019-2024
• 世界のがん診断における人工知能市場の予測：規模と成長, 2024-2029, 2034F
• 世界のがん診断における人工知能総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界のがん診断における人工知能市場：コンポーネント別、実績と予測, 2019-2024, 2024-2029F, 2034F
• ソフトウェアソリューション
• ハードウェア
• サービス
• 世界のがん診断における人工知能市場：がんタイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 乳がん
• 肺がん
• 前立腺がん
• 大腸がん
• 脳腫瘍
• その他のタイプ
• 世界のがん診断における人工知能市場：用途別、実績と予測, 2019-2024, 2024-2029F, 2034F
• スクリーニングと診断
• 腫瘍の特定
• 監視
• 治療
• 世界のがん診断における人工知能市場：エンドユーザー別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 病院
• 医学研究
• 診断センター
• 受託研究機関
• 世界のがん診断における人工知能市場、タイプ別サブセグメンテーション：ソフトウェアソリューション、実績と予測, 2019-2024, 2024-2029F, 2034F
• 画像解析ソフトウェア
• 予測分析ソフトウェア
• 意思決定支援システム
• データ管理プラットフォーム
• 世界のがん診断における人工知能市場、タイプ別サブセグメンテーション：ハードウェア、実績と予測, 2019-2024, 2024-2029F, 2034F
• イメージングデバイス
• バイオマーカー検出装置
• コンピューティングインフラストラクチャ
• 世界のがん診断における人工知能市場、タイプ別サブセグメンテーション：サービス、実績と予測, 2019-2024, 2024-2029F, 2034F
• コンサルティングサービス
• 実装サービス
• メンテナンスおよびサポートサービス
• トレーニングサービス

第7章 地域別・国別分析

• 世界のがん診断における人工知能市場：地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 世界のがん診断における人工知能市場：国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• がん診断における人工知能市場：競合情勢
• がん診断における人工知能市場：企業プロファイル
  • Microsoft Corporation Overview, Products and Services, Strategy and Financial Analysis
  • Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Johnson & Johnson's Overview, Products and Services, Strategy and Financial Analysis
  • Siemens Overview, Products and Services, Strategy and Financial Analysis
  • Roche Holding AG Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• Google LCC
• International Business Machines Corporation
• Thermo Fisher Scientific Inc.
• Oracle Corporation
• GE Healthcare
• Illumina Inc.
• Bio Rad Laboratories Inc.
• Flatiron Health
• Tempus Labs Inc.
• Paige AI Inc.
• OncoHealth Corporation
• Path AI Inc.
• Aidoc
• Sophia Genetics SA
• Digital Diagnostics Inc.

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• がん診断における人工知能市場2029：新たな機会を提供する国
• がん診断における人工知能市場2029：新たな機会を提供するセグメント
• がん診断における人工知能市場2029：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

Artificial intelligence (AI) in cancer diagnostics involves the application of advanced computational techniques and algorithms to aid in the detection, diagnosis, and characterization of cancer. This technology is employed to enhance the speed, accuracy, and efficiency of cancer imaging tests, achieving comparable accuracy to radiologists in detecting mammographic abnormalities.

The main components of artificial intelligence in cancer diagnostics include software solutions, hardware, and services. Software solutions are customized applications or systems designed to address specific business needs, and AI-powered software in cancer diagnostics utilizes machine learning algorithms and computer vision techniques to analyze medical images, genetic data, and clinical records. This enables accurate cancer detection, classification, and treatment prediction. These AI applications are utilized in various types of cancer such as breast cancer, lung cancer, prostate cancer, colorectal cancer, and brain tumors. They are applied in screening and diagnosis, tumor identification, surveillance, and treatment planning and are used by hospitals, medical research institutes, diagnostic centers, and contract research organizations.

The artificial intelligence in cancer diagnostics research report is one of a series of new reports from The Business Research Company that provides artificial intelligence in cancer diagnostics market statistics, including the artificial intelligence in cancer diagnostics industry's global market size, regional shares, competitors with an artificial intelligence in cancer diagnostics market share, detailed artificial intelligence in cancer diagnostics market segments, market trends and opportunities, and any further data you may need to thrive in the artificial intelligence in cancer diagnostics industry. This artificial intelligence in cancer diagnostics market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The artificial intelligence in cancer diagnostics market size has grown exponentially in recent years. It will grow from $0.39 billion in 2024 to $0.52 billion in 2025 at a compound annual growth rate (CAGR) of 32.6%. The growth in the historic period can be attributed to increased cancer incidence, big data availability, rise of personalized oncology, precision medicine initiatives, integration of genomic data

The artificial intelligence in cancer diagnostics market size is expected to see exponential growth in the next few years. It will grow to $1.55 billion in 2029 at a compound annual growth rate (CAGR) of 31.2%. The growth in the forecast period can be attributed to clinician shortages, population aging, global telemedicine adoption, integration of ai with electronic health records, growing cancer screening programs. Major trends in the forecast period include rapid advances in ai algorithms, advancements in imaging technology, technological innovations in pathology, advancements in radiomics and radiogenomics, drug development, deep learning, ai for predictive biomarker discovery.

The increasing prevalence of cancer is anticipated to drive the growth of artificial intelligence in the cancer diagnostics market in the future. Cancer is characterized by uncontrolled cell growth affecting various organs, contributing significantly to morbidity and mortality worldwide. Artificial intelligence plays a crucial role in cancer diagnostics by enabling accurate and efficient analysis of medical imaging data, which aids in the early detection and precise classification of cancerous lesions. For instance, in February 2024, the World Health Organization, a Switzerland-based intergovernmental organization, reported that in 2022, there were approximately 20 million new cancer cases, resulting in 9.7 million deaths. An estimated 53.5 million individuals were alive five years after their cancer diagnosis. Therefore, the rising prevalence of cancer is expected to boost the growth of artificial intelligence in the cancer diagnostics market.

The ongoing enhancement of healthcare infrastructure is poised to drive the artificial intelligence in cancer diagnostics market in the foreseeable future. Healthcare infrastructure, encompassing the fundamental framework, facilities, resources, and processes supporting healthcare services, is crucial for the seamless integration of AI technologies. A robust healthcare infrastructure enables the incorporation of AI into clinical workflows, ensures data security and privacy, and facilitates collaborative efforts across healthcare institutions. Notably, in March 2022, the Department of Health and Aged Care in Australia announced a substantial allocation of $132 billion to healthcare infrastructure in 2022-23, rising to $140 billion in 2025-26. This commitment of $537 billion over the next four years underscores the pivotal role of improving healthcare infrastructure in propelling the artificial intelligence in cancer diagnostics market.

Technological advancement emerges as a prominent trend gaining momentum in the artificial intelligence in the cancer diagnostics market. Key market players are focused on developing innovative tools catering to various cancer conditions, thereby fortifying their market positions. For instance, in March 2023, Qritive, a Singapore-based company specializing in AI-powered solutions for pathologists, introduced QAi Prostate-an advanced AI-powered tool for prostate cancer diagnosis. QAi Prostate accurately identifies prostatic adenocarcinoma regions and classifies malignant and benign tumor areas in biopsy tissue samples. This tool provides detailed summaries of tumor size and percentage for each slide or region of interest, empowering pathologists to make informed decisions rapidly.

Strategic collaborations are a significant approach adopted by major companies operating in the artificial intelligence in cancer diagnostics market to expedite the deployment of AI-powered technologies. Such partnerships leverage the strengths and resources of collaborating entities for mutual benefits. For instance, in October 2023, F. Hoffmann-La Roche AG collaborated with Ibex Medical Analytics and Amazon Web Services. This collaboration allows pathology labs to utilize the navify Digital Pathology software platform to access Ibex's AI-powered decision support capabilities, aiding physicians in diagnosing breast and prostate cancer. The partnership between Ibex Medical Analytics, Roche, and Amazon Web Services generates innovative AI-powered processes, fostering advancements in digital pathology and offering scalable solutions for pathology laboratories.

In January 2022, RadNet, a US-based radiology information technology solutions company, acquired Aidence Holding B.V. and Quantib B.V. This strategic acquisition addresses opportunities in lung and prostate cancer diagnosis and screening through artificial intelligence. Aidence Holding B.V., based in the Netherlands, focuses on AI-powered clinical applications for the lung cancer pathway, while Quantib B.V. specializes in AI and machine learning solutions for prostate cancer.

Major companies operating in the artificial intelligence in cancer diagnostics market include Microsoft Corporation, Pfizer Inc., Johnson & Johnson's, Siemens, Roche Holding AG, Google LCC, International Business Machines Corporation, Thermo Fisher Scientific Inc., Oracle Corporation, GE Healthcare, Illumina Inc., Bio Rad Laboratories Inc., Flatiron Health, Tempus Labs Inc., Paige AI Inc., OncoHealth Corporation, Path AI Inc., Aidoc, Sophia Genetics SA, Digital Diagnostics Inc., Prognos Health, Aidence, Kheiron Medical Technologies Limited, Zebra Medical Vision, Niramai, Enlitic Inc., Therapixel, Medial EarlySign Ltd., Freenome, SkinVision B.V.

North America was the largest region in the artificial intelligence in cancer diagnostics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the artificial intelligence in cancer diagnostics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the artificial intelligence in cancer diagnostics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Spain, Canada.

The artificial intelligence (AI) in the cancer diagnostics market consists of revenues earned by entities by providing services such as data analysis, image recognition, personalized medicine, and decision support. The market value includes the value of related goods sold by the service provider or included within the service offering. The artificial intelligence (AI) in the cancer diagnostics market also includes sales of AI-based diagnostic tools, predictive analytics tools, and a virtual tumor board. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Artificial Intelligence In Cancer Diagnostics Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on artificial intelligence in cancer diagnostics market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for artificial intelligence in cancer diagnostics ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The artificial intelligence in cancer diagnostics market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Component: Software Solutions; Hardware; Services
• 2) By Cancer Type: Breast Cancer; Lung Cancer; Prostate Cancer; Colorectal Cancer; Brain Tumor; Other Types
• 3) By Application: Screening And Diagnosis; Tumor Identification; Surveillance; Treatment
• 4) By End-User: Hospitals; Medical Research Institute; Diagnostic Centers; Contract Research Organization
• Subsegments:
• 1) By Software Solutions: Imaging Analysis Software; Predictive Analytics Software; Decision Support Systems; Data Management Platforms
• 2) By Hardware: Imaging Devices; Biomarkers Detection Equipment; Computing Infrastructure
• 3) By Services: Consulting Services; Implementation Services; Maintenance And Support Services; Training Services
• Companies Mentioned: Microsoft Corporation; Pfizer Inc.; Johnson & Johnson's; Siemens; Roche Holding AG
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Artificial Intelligence In Cancer Diagnostics Market Characteristics

3. Artificial Intelligence In Cancer Diagnostics Market Trends And Strategies

4. Artificial Intelligence In Cancer Diagnostics Market - Macro Economic Scenario including the impact of Interest Rates, Inflation, Geopolitics and Covid And Recovery on the Market

5. Global Artificial Intelligence In Cancer Diagnostics Growth Analysis And Strategic Analysis Framework

• 5.1. Global Artificial Intelligence In Cancer Diagnostics PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Artificial Intelligence In Cancer Diagnostics Market Growth Rate Analysis
• 5.4. Global Artificial Intelligence In Cancer Diagnostics Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Artificial Intelligence In Cancer Diagnostics Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Artificial Intelligence In Cancer Diagnostics Total Addressable Market (TAM)

6. Artificial Intelligence In Cancer Diagnostics Market Segmentation

• 6.1. Global Artificial Intelligence In Cancer Diagnostics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Software Solutions
• Hardware
• Services
• 6.2. Global Artificial Intelligence In Cancer Diagnostics Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Breast Cancer
• Lung Cancer
• Prostate Cancer
• Colorectal Cancer
• Brain Tumor
• Other Types
• 6.3. Global Artificial Intelligence In Cancer Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Screening And Diagnosis
• Tumor Identification
• Surveillance
• Treatment
• 6.4. Global Artificial Intelligence In Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospitals
• Medical Research Institute
• Diagnostic Centers
• Contract Research Organization
• 6.5. Global Artificial Intelligence In Cancer Diagnostics Market, Sub-Segmentation Of Software Solutions, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Imaging Analysis Software
• Predictive Analytics Software
• Decision Support Systems
• Data Management Platforms
• 6.6. Global Artificial Intelligence In Cancer Diagnostics Market, Sub-Segmentation Of Hardware, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Imaging Devices
• Biomarkers Detection Equipment
• Computing Infrastructure
• 6.7. Global Artificial Intelligence In Cancer Diagnostics Market, Sub-Segmentation Of Services, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Consulting Services
• Implementation Services
• Maintenance And Support Services
• Training Services

7. Artificial Intelligence In Cancer Diagnostics Market Regional And Country Analysis

• 7.1. Global Artificial Intelligence In Cancer Diagnostics Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Artificial Intelligence In Cancer Diagnostics Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Artificial Intelligence In Cancer Diagnostics Market

• 8.1. Asia-Pacific Artificial Intelligence In Cancer Diagnostics Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Artificial Intelligence In Cancer Diagnostics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Artificial Intelligence In Cancer Diagnostics Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Artificial Intelligence In Cancer Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Artificial Intelligence In Cancer Diagnostics Market

• 9.1. China Artificial Intelligence In Cancer Diagnostics Market Overview
• 9.2. China Artificial Intelligence In Cancer Diagnostics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Artificial Intelligence In Cancer Diagnostics Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Artificial Intelligence In Cancer Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Artificial Intelligence In Cancer Diagnostics Market

• 10.1. India Artificial Intelligence In Cancer Diagnostics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Artificial Intelligence In Cancer Diagnostics Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Artificial Intelligence In Cancer Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Artificial Intelligence In Cancer Diagnostics Market

• 11.1. Japan Artificial Intelligence In Cancer Diagnostics Market Overview
• 11.2. Japan Artificial Intelligence In Cancer Diagnostics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Artificial Intelligence In Cancer Diagnostics Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Artificial Intelligence In Cancer Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Artificial Intelligence In Cancer Diagnostics Market

• 12.1. Australia Artificial Intelligence In Cancer Diagnostics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Artificial Intelligence In Cancer Diagnostics Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Artificial Intelligence In Cancer Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Artificial Intelligence In Cancer Diagnostics Market

• 13.1. Indonesia Artificial Intelligence In Cancer Diagnostics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Artificial Intelligence In Cancer Diagnostics Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Artificial Intelligence In Cancer Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Artificial Intelligence In Cancer Diagnostics Market

• 14.1. South Korea Artificial Intelligence In Cancer Diagnostics Market Overview
• 14.2. South Korea Artificial Intelligence In Cancer Diagnostics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Artificial Intelligence In Cancer Diagnostics Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Artificial Intelligence In Cancer Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Artificial Intelligence In Cancer Diagnostics Market

• 15.1. Western Europe Artificial Intelligence In Cancer Diagnostics Market Overview
• 15.2. Western Europe Artificial Intelligence In Cancer Diagnostics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Artificial Intelligence In Cancer Diagnostics Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Artificial Intelligence In Cancer Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Artificial Intelligence In Cancer Diagnostics Market

• 16.1. UK Artificial Intelligence In Cancer Diagnostics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Artificial Intelligence In Cancer Diagnostics Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Artificial Intelligence In Cancer Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Artificial Intelligence In Cancer Diagnostics Market

• 17.1. Germany Artificial Intelligence In Cancer Diagnostics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Artificial Intelligence In Cancer Diagnostics Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Artificial Intelligence In Cancer Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Artificial Intelligence In Cancer Diagnostics Market

• 18.1. France Artificial Intelligence In Cancer Diagnostics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Artificial Intelligence In Cancer Diagnostics Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Artificial Intelligence In Cancer Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Artificial Intelligence In Cancer Diagnostics Market

• 19.1. Italy Artificial Intelligence In Cancer Diagnostics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Artificial Intelligence In Cancer Diagnostics Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Artificial Intelligence In Cancer Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Artificial Intelligence In Cancer Diagnostics Market

• 20.1. Spain Artificial Intelligence In Cancer Diagnostics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Artificial Intelligence In Cancer Diagnostics Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Artificial Intelligence In Cancer Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Artificial Intelligence In Cancer Diagnostics Market

• 21.1. Eastern Europe Artificial Intelligence In Cancer Diagnostics Market Overview
• 21.2. Eastern Europe Artificial Intelligence In Cancer Diagnostics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Artificial Intelligence In Cancer Diagnostics Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Artificial Intelligence In Cancer Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Artificial Intelligence In Cancer Diagnostics Market

• 22.1. Russia Artificial Intelligence In Cancer Diagnostics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Artificial Intelligence In Cancer Diagnostics Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Artificial Intelligence In Cancer Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Artificial Intelligence In Cancer Diagnostics Market

• 23.1. North America Artificial Intelligence In Cancer Diagnostics Market Overview
• 23.2. North America Artificial Intelligence In Cancer Diagnostics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Artificial Intelligence In Cancer Diagnostics Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Artificial Intelligence In Cancer Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Artificial Intelligence In Cancer Diagnostics Market

• 24.1. USA Artificial Intelligence In Cancer Diagnostics Market Overview
• 24.2. USA Artificial Intelligence In Cancer Diagnostics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Artificial Intelligence In Cancer Diagnostics Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Artificial Intelligence In Cancer Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Artificial Intelligence In Cancer Diagnostics Market

• 25.1. Canada Artificial Intelligence In Cancer Diagnostics Market Overview
• 25.2. Canada Artificial Intelligence In Cancer Diagnostics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Artificial Intelligence In Cancer Diagnostics Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Artificial Intelligence In Cancer Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Artificial Intelligence In Cancer Diagnostics Market

• 26.1. South America Artificial Intelligence In Cancer Diagnostics Market Overview
• 26.2. South America Artificial Intelligence In Cancer Diagnostics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Artificial Intelligence In Cancer Diagnostics Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Artificial Intelligence In Cancer Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Artificial Intelligence In Cancer Diagnostics Market

• 27.1. Brazil Artificial Intelligence In Cancer Diagnostics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Artificial Intelligence In Cancer Diagnostics Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Artificial Intelligence In Cancer Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Artificial Intelligence In Cancer Diagnostics Market

• 28.1. Middle East Artificial Intelligence In Cancer Diagnostics Market Overview
• 28.2. Middle East Artificial Intelligence In Cancer Diagnostics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Artificial Intelligence In Cancer Diagnostics Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Artificial Intelligence In Cancer Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Artificial Intelligence In Cancer Diagnostics Market

• 29.1. Africa Artificial Intelligence In Cancer Diagnostics Market Overview
• 29.2. Africa Artificial Intelligence In Cancer Diagnostics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Artificial Intelligence In Cancer Diagnostics Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Artificial Intelligence In Cancer Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Artificial Intelligence In Cancer Diagnostics Market Competitive Landscape And Company Profiles

• 30.1. Artificial Intelligence In Cancer Diagnostics Market Competitive Landscape
• 30.2. Artificial Intelligence In Cancer Diagnostics Market Company Profiles
  • 30.2.1. Microsoft Corporation Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Johnson & Johnson's Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Siemens Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Roche Holding AG Overview, Products and Services, Strategy and Financial Analysis

31. Artificial Intelligence In Cancer Diagnostics Market Other Major And Innovative Companies

• 31.1. Google LCC
• 31.2. International Business Machines Corporation
• 31.3. Thermo Fisher Scientific Inc.
• 31.4. Oracle Corporation
• 31.5. GE Healthcare
• 31.6. Illumina Inc.
• 31.7. Bio Rad Laboratories Inc.
• 31.8. Flatiron Health
• 31.9. Tempus Labs Inc.
• 31.10. Paige AI Inc.
• 31.11. OncoHealth Corporation
• 31.12. Path AI Inc.
• 31.13. Aidoc
• 31.14. Sophia Genetics SA
• 31.15. Digital Diagnostics Inc.

32. Global Artificial Intelligence In Cancer Diagnostics Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Artificial Intelligence In Cancer Diagnostics Market

34. Recent Developments In The Artificial Intelligence In Cancer Diagnostics Market

35. Artificial Intelligence In Cancer Diagnostics Market High Potential Countries, Segments and Strategies

• 35.1 Artificial Intelligence In Cancer Diagnostics Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Artificial Intelligence In Cancer Diagnostics Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Artificial Intelligence In Cancer Diagnostics Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer